Pages that link to "Q34605959"
Jump to navigation
Jump to search
The following pages link to International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons (Q34605959):
Displaying 50 items.
- Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies (Q26782646) (← links)
- Spinal osteosarcoma (Q26996533) (← links)
- Children's Oncology Group's 2013 blueprint for research: bone tumors (Q27027664) (← links)
- The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation (Q27311269) (← links)
- Review of Osteosarcoma and Current Management (Q28077590) (← links)
- Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. (Q30235105) (← links)
- Incidence and survival of malignant bone sarcomas in England 1979-2007. (Q33274226) (← links)
- Incidence patterns of primary bone cancer in taiwan (2003-2010): a population-based study (Q33275216) (← links)
- LIM mineralization protein-1 inhibits the malignant phenotypes of human osteosarcoma cells (Q33580856) (← links)
- β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour (Q33645914) (← links)
- Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1. (Q33809324) (← links)
- A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma (Q33914489) (← links)
- Animal models in osteosarcoma (Q33917772) (← links)
- Review of mifamurtide in the treatment of patients with osteosarcoma (Q33947618) (← links)
- Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase family (Q33948137) (← links)
- Osteosarcoma in children 5 years of age or younger at initial diagnosis (Q34049526) (← links)
- Wnt/β-Catenin Expression Does Not Correlate with Serum Alkaline Phosphatase Concentration in Canine Osteosarcoma Patients (Q34056006) (← links)
- Strategies for the targeted delivery of therapeutics for osteosarcoma (Q34179495) (← links)
- UK Guidelines for the Management of Bone Sarcomas (Q34496992) (← links)
- Using epidemiology and genomics to understand osteosarcoma etiology (Q34627943) (← links)
- NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han population (Q35173942) (← links)
- Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma (Q35190158) (← links)
- Preclinical mouse models of osteosarcoma (Q35575644) (← links)
- Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care? (Q35653897) (← links)
- Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008 (Q35766581) (← links)
- Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study. (Q35791674) (← links)
- Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review (Q35848126) (← links)
- At-Risk Populations for Osteosarcoma: The Syndromes and Beyond (Q35897747) (← links)
- Expression of epidermal growth factor-like domain 7 correlates with clinicopathological features of osteosarcoma (Q35993067) (← links)
- Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model. (Q35993110) (← links)
- A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma (Q36029709) (← links)
- Lung cells support osteosarcoma cell migration and survival (Q36260257) (← links)
- Germline TP53 variants and susceptibility to osteosarcoma. (Q36294747) (← links)
- The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. (Q36298450) (← links)
- Height at diagnosis and birth-weight as risk factors for osteosarcoma (Q36387760) (← links)
- Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study (Q36429557) (← links)
- Genetically engineered mouse models and human osteosarcoma (Q36468644) (← links)
- Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma (Q36502721) (← links)
- The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. (Q36537388) (← links)
- Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison (Q36803705) (← links)
- Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance. (Q36862527) (← links)
- Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro (Q37045893) (← links)
- Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. (Q37090949) (← links)
- Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma (Q37103971) (← links)
- Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review). (Q37255459) (← links)
- Bone formation induced by BMP-2 in human osteosarcoma cells (Q37313318) (← links)
- Celastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro (Q37406992) (← links)
- HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignancies (Q37650306) (← links)
- Prognostic markers in osteosarcoma (Q37687395) (← links)
- Long non-coding RNAs in osteosarcoma (Q37746352) (← links)